{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:24:48Z","timestamp":1760189088248},"reference-count":31,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.3109\/08916930008994096","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T18:24:47Z","timestamp":1260210287000},"page":"217-228","source":"Crossref","is-referenced-by-count":9,"title":["Gliadin Antibodies in Adult Insulin-Dependent Diabetes - Autoimmune and Immunogenetic Correlates"],"prefix":"10.1080","volume":"32","author":[{"given":"Klas","family":"Sj\u00f6berg","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Lund, University Hospital, Malm\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Wassmuth","sequence":"additional","affiliation":[{"name":"Department of Medicine III, Institute for Clinical Immunology, University of Erlangen-N\u00fcrnberg, Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Reichstetter","sequence":"additional","affiliation":[{"name":"Department of Medicine III, Institute for Clinical Immunology, University of Erlangen-N\u00fcrnberg, Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Fredrik","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Lund, University Hospital, Malm\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla-Britt","family":"Ericsson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Lund, University Hospital, Malm\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sten","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Lund, University Hospital, Malm\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909092243"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02087768"},{"key":"e_1_2_1_4_1","first-page":"631","article-title":"The prevalence of coeliac disease in adult diabetes mellitus","volume":"87","author":"Page S R","year":"1994","unstructured":"Page S R, Lloyd C A, Hill P G, Peacock I, Holmes G KT. The prevalence of coeliac disease in adult diabetes mellitus. QJM 1994; 87: 631\u20137","journal-title":"QJM"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409092508"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.6.844"},{"key":"e_1_2_1_7_1","first-page":"18","article-title":"Organspecific autoantibodies in coeliac disease: do they represent an epiphenomenon or the expression of associated autoimmune disorders?","volume":"29","author":"Volta U","year":"1997","unstructured":"Volta U, De-Franceschi L, Molinaro N, Tetta C, Bianchi F B. Organspecific autoantibodies in coeliac disease: do they represent an epiphenomenon or the expression of associated autoimmune disorders?. Ital J Gastroenterol Hepatol 1997; 29: 18\u201321","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"e_1_2_1_8_1","first-page":"151","article-title":"Autoantibodies and autoimmune diseases in young diabetics","volume":"13","author":"Kontiainen S","year":"1990","unstructured":"Kontiainen S, Schlenzka A, Koskimies S, Rilva A, Maenpaa J. Autoantibodies and autoimmune diseases in young diabetics. Diabetes Research 1990; 13: 151\u201356","journal-title":"Diabetes Research"},{"key":"e_1_2_1_9_1","first-page":"51","article-title":"HLA-associated disease susceptibility - which genes are primarily involved?","volume":"3","author":"Thorsby E","year":"1995","unstructured":"Thorsby E. HLA-associated disease susceptibility - which genes are primarily involved?. The Immunologist 1995; 3\/2: 51\u201358","journal-title":"The Immunologist"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90912-V"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199306000-00009"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1994.tb06018.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409090472"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199105000-00001"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1998.00256.x"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0797-797"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1642451"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051291"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365518409083601"},{"key":"e_1_2_1_20_1","first-page":"147","article-title":"Anti-brush border antibodies (ABBA) in Crohn's disease","volume":"9","author":"Skogh T","year":"1982","unstructured":"Skogh T, Heuman R, Tagesson C. Anti-brush border antibodies (ABBA) in Crohn's disease. J Clin Lab Immunol 1982; 9: 147\u2013150","journal-title":"J Clin Lab Immunol"},{"key":"e_1_2_1_21_1","first-page":"405","article-title":"HLA DPB alleles provide protection against Crohn's disease in Caucasians","volume":"6","author":"Wassmuth R","year":"1994","unstructured":"Wassmuth R, Keller Y, Thomson G, Starck M, Lindhagen T, Holmberg E., et al. HLA DPB alleles provide protection against Crohn's disease in Caucasians. Eur J Gastroenterol Hepatol 1994; 6: 405\u201311","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-313X.1991.tb00032.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01719235"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(93)90556-G"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112220"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1955.tb01348.x"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1955.tb01285.x"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1994.tb02291.x"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-3758(77)90022-2"},{"key":"e_1_2_1_30_1","first-page":"169","volume-title":"Anticoagulants, Physiologic, Pathologic and Pharmacologic","author":"Lorand L","year":"1994","unstructured":"Lorand L. Acquired inhibitors of fibrin stabilization: A class of hemorrhagic disorders of diverse origins. Anticoagulants, Physiologic, Pathologic and Pharmacologic, D Green. CRC., Cleveland, OH 1994; 169\u201391"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/358155a0"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-313X.1995.tb00282.x"}],"container-title":["Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/08916930008994096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T08:19:52Z","timestamp":1720685992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/08916930008994096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.3109\/08916930008994096"],"URL":"https:\/\/doi.org\/10.3109\/08916930008994096","relation":{},"ISSN":["0891-6934","1607-842X"],"issn-type":[{"value":"0891-6934","type":"print"},{"value":"1607-842X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}